ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
The influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic
This article has 13 authors:Reviewed by ScreenIT
-
Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?
This article has 5 authors:Reviewed by ScreenIT
-
Post-COVID-19 perceived stigma-discrimination scale: psychometric development and evaluation
This article has 3 authors:Reviewed by ScreenIT
-
SARS‐CoV‐2 infection in pregnancy in Denmark—characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population‐based cohort study
This article has 40 authors:Reviewed by ScreenIT
-
A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies
This article has 10 authors:Reviewed by ScreenIT
-
What about using sniffin’ sticks 12 items test to screen post-COVID-19 olfactory disorders?
This article has 16 authors:Reviewed by ScreenIT
-
NEWS-2 Score Assessment of Inpatient Referral during the COVID 19 Epidemic
This article has 8 authors:Reviewed by ScreenIT
-
Modelling the effect of an improved trace and isolate system in the wake of a highly transmissible Covid-19 variant with potential vaccine escape
This article has 1 author:Reviewed by ScreenIT
-
Percolation across households in mechanistic models of non-pharmaceutical interventions in SARS-CoV-2 disease dynamics
This article has 10 authors:Reviewed by ScreenIT
-
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
This article has 15 authors:Reviewed by ScreenIT